| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Preventive Oncology, Cancer Care Ontario M5G 2L7 [J. A. K., N. F. B.]; Division of Epidemiology and Statistics, Ontario Cancer Institute M5G 2M9 [L. J. M., C. V. G., G. A. L., D. L. T., N. F. B.]; and Imaging Research Institute, Sunnybrook Health Science Centre [J. W. B., M. J. Y.], Toronto, Ontario M4N 3M5, Canada
| Abstract |
|---|
|
|
|---|
Differences between 2-year and baseline values of macronutrients (averaged over 3 nonconsecutive days of food intake) were calculated. We examined the effect of dietary variables, adjusted for changes in total calorie intake and weight and for family history of breast cancer, on changes in area of density and percentage of density using linear regression. Reduction in total or saturated fat intake or cholesterol intake was significantly associated with decreased dense area (p
.004). The most significant dietary variable associated with reduction in percentage of density was reduction in dietary cholesterol intake (P = 0.001), although reducing saturated fat intake was of borderline significance (P = 0.05). The effect of the membership in the intervention and control groups on change in area of density or percentage of density was reduced by models that included changes in intake of any fat, or cholesterol, or carbohydrates.
The observation of an effect of diet at menopause on breast density, a marker of increased risk of breast cancer, may be an indication that exposures at this time have an enhanced effect on subsequent risk.
| Introduction |
|---|
|
|
|---|
To examine the effects of a wider range of dietary fat intake on breast cancer risk we are conducting a randomized controlled trial of dietary intervention in women identified to be at increased risk of breast cancer due to the presence in the mammogram of extensive areas of radiologically dense breast tissue, a risk factor for breast cancer (4, 5, 6) .
In our trial, women with extensive mammographic densities are randomized to either a control group that continues usual diet, or to an intervention group that receives intensive counseling to adopt a low-fat, high-carbohydrate diet. Both groups in the trial are monitored by collecting food records at specified intervals, and are asked to have mammograms every 2 years that are compared with mammograms taken at baseline.
Initial results of the trial in 817 participants showed that after 2 years women in the intervention group experienced a reduction in total area of breast density significantly greater than that seen in controls (7) . This effect was strongly influenced by menopausal status. No effect was seen in women who were postmenopausal at entry. An effect was seen only in those who were premenopausal at entry to the trial. This effect was greatest among women who became postmenopausal at 2 years. We expect any differences between control and intervention groups in this randomized trial to be largely due to differences in diet, and that the effect of dietary variables should be most easy to identify in the group in whom the effect was greatest. Therefore, the purpose of the analyses presented here was to determine which macronutrient(s) could account for the observed change in breast density in women in whom the change was largest (i.e., in women who became postmenopausal after entry) and to determine how much of the variation in change in breast density could be accounted for by dietary and other variables. Results for women who remained premenopausal or who were postmenopausal at baseline will be discussed in a separate publication, because results differed among the three menopausal groups.
| Materials and Methods |
|---|
|
|
|---|
2 years after randomization, the area of dense tissue and total area were measured using quantitative methods, and percentage of density was calculated. In the present study, we examine the relationship between change in area of dense tissue and percentage of density in relation to change in nutrient intake over the previous 2 years. We have limited the analysis here to women who were premenopausal at entry to the trial and who became postmenopausal within 2 years of entry, because it was in this group that the effect of dietary intervention on mammographic density was greatest. Subjects were classified as premenopausal if they had a menstrual period in the previous 6 months, were on HRT3
and <50 years of age, or had a hysterectomy without oophorectomy and were <50 years of age. Menopause was defined as 6 consecutive months without menstruating, being on HRT and
50 years of age, having a hysterectomy without oophorectomy and being
50 years, or having a hysterectomy with oophorectomy while still menstruating. | Dietary Intervention Trial. |
|---|
|
|
|---|
50% of the breast area were enrolled in the study and randomized either to a dietary intervention arm or a control arm. The intervention involved intensive individual dietary counseling aimed at reducing total fat intake to a target of 15% of calories while maintaining caloric intake by increasing consumption of carbohydrate. Controls received general advice about nutrition but were not counseled to change their intake of fat. Subjects in the intervention group were seen every month for the 1st year and every 3 months in the 2nd year. Controls were seen every 4 months in the 1st year and every 3 months in the 2nd year. At each visit, subjects were asked to provide 3 nonconsecutive days of food records, which were reviewed with each subject by a dietitian to ensure completeness. Nutrient analysis of food records was performed using the Minnesota Nutrient Data System software developed by the Nutrition Coordinating Center, University of Minneapolis (Minneapolis, MN). Information on nondietary variables, including menstrual history, was collected at baseline and updated 1 and 2 years after randomization.
| Mammographic Measurements. |
|---|
|
|
|---|
Further details of this method, including inter- and intraobserver reliability (intraclass coefficients of about 0.9) and the relationship of the measurements to cancer risk (relative risks of 4, 5, 6 between the highest and lowest categories of density), are described elsewhere (8, 9, 10) .
| Ethics. |
|---|
|
|
|---|
| Statistical Analysis. |
|---|
|
|
|---|
The following nondietary variables at baseline were examined for an effect on change in area of density and percent density: age, family history of breast cancer (defined as reporting any relative with breast cancer), being a smoker, ever having been pregnant, ever having breast-fed, ever having used oral contraceptives, age at menarche, age at first birth, and level of physical activity (on a 7-point scale). In addition, physical activity at 2 years and change in physical activity (using four categories) were also examined. Users of HRT were defined for analysis as those who were using HRT at either baseline or at 2 years. As women could be using HRT at either or both time points, the number of women within each of these subcategories was insufficient for a more detailed analysis.
Dietary variables tested in the models consisted of change in intake of the following macronutrients: total fat, type of fat (saturated, monounsaturated, and polyunsaturated), cholesterol, total carbohydrates, total fiber, type of fiber (insoluble and soluble), and protein. The intakes of all dietary components were measured in grams except cholesterol, which was measured in milligrams. Change in total calorie intake (in kilocalories) and weight change were included as potential confounders in all models testing the effect of changes in macronutrient intake.
Finally, the effect of the addition of each dietary variable on the P of the group variable was also considered to determine which dietary variables best "explained" the observed group effect, defined by the value of R2, indicating the proportion of variance explained (11) . The values of R2 shown are adjusted for the number of variables in the model.
Change in area and percentage of mammographic density were approximately normally distributed and were not transformed.
| Results |
|---|
|
|
|---|
50 years at 2 years; (c) four (1 I; 3 Cs) were classified because of hysterectomy with oophorectomy while still menstruating; and (d) thirty-one (16 Is; 15 Cs) were classified because they were on HRT and
50 years of age at 2 years. The mean change in area of density and mean change in percent density were similar in these 78 subjects and the whole group of 89 (change in area of density, -8.2 cm2 and -8.1 cm2, respectively; change in percent density, -8.5% and -8.5%, respectively). Over 2 years, the intervention group experienced a mean decrease in dense area (-11.0 cm2 versus -4.5 cm2; P = 0.004) and in percent density (-11.0% versus -5.2%; P = 0.025) that was more than twice as great as that experienced by the control group. These changes were much greater than those observed in 453 women premenopausal at baseline and at 2 years with complete information, and excluding extreme outliers. Among these women, the intervention group had a marginally significant greater decrease in dense area (-3.0 cm2 versus -1.0 cm2; P = 0.08) and no difference in change in percent density (-1.1% versus -1.6%; P = 0.55). Postmenopausal women with complete information (n = 181) experienced little change in either the intervention or the control group in either dense area (-1.6 cm2 versus -0.9 cm2; P = 0.68) or percent density (+1.2% versus +0.4%; P = 0.57). | Baseline Characteristics. |
|---|
|
|
|---|
|
|
| Nondietary Variables: Influence on Change in Density. |
|---|
|
|
|---|
| Macronutrient Variables: Influence on Change in Density. |
|---|
|
|
|---|
|
The median change in dietary fat intake in the intervention group was from 5731 g/day, giving an estimated average reduction of 5.61 cm2 in the area of dense breast tissue. Intake of saturated fat, which was the most significant subtype of fat, was reduced from a median of 21 g/day to 11 g/day, resulting in an estimated average reduction of 5.54 cm2 in the area of dense breast tissue and a reduction of 3.93 in the percentage of breast density. Intake of dietary cholesterol, which was the most significant nutrient for both area and percent density, was reduced from a median of 229 mg/day to 150 mg/day, resulting in an estimated average 3.27 cm2 reduction in the area of dense tissue and a reduction of 3.52 in percent density.
On the basis of the R2 values in Table 3
, change in cholesterol intake accounted for more of the variation in density change than any other variable. A model including changes in cholesterol intake, family history, weight change and change in total calories resulted in an adjusted R2 of 0.18 for both area of density and percent density.
We next sought to "explain" the effect of group membership (intervention or control) on the reduction in breast density by examining the effects on the statistical significance of group membership on change in breast density by including dietary and nondietary variables in a series of models whose results are shown in Table 4
. With change in dense area as the dependent variable, models that included change in total calorie intake, change in weight, family history, and either change in intake of any fat, or cholesterol, or carbohydrates, all reduced the statistical significance of the group effect. Change in intake of total fat, saturated fat, or cholesterol had the largest influence on the group variable.
|
| Discussion |
|---|
|
|
|---|
Family history, defined as any relative with breast cancer, was significantly associated with a smaller decrease in area of breast density and percent density at menopause. Thus, failure to decrease density as much as other women at menopause may contribute to the continuing greater risk of breast cancer experienced by women with a family history of breast cancer.
As expected, women in the intervention group had lower intakes of all of the types of fat and cholesterol than controls, and all of these dietary differences were related to the decrease in area of dense tissue in the breast. Only changes in saturated fat and dietary cholesterol intake were related to the magnitude of the decrease in percent density. Changes in carbohydrates, fiber, and protein intake were not significantly related to density change (although change in protein intake was related to change in total area, which affects percent density). The variables associated with the largest R2 for the observed change in dense area were changes in total fat, saturated fat, and dietary cholesterol. Changes in dietary cholesterol and saturated fat best explained the observed change in percent density. About 18% of the observed variation in change in area of density in women becoming postmenopausal was accounted for by change in cholesterol intake, change in total calorie intake, weight change, and family history, although much variation is still unaccounted for.
All of the models presented here include only one dietary variable (other than change in total calories) for two reasons. One reason is the high correlation between some of the dietary variables. The other reason is concern that, if measurement error varies among the dietary variables, the relative importance of each variable could be obscured when they are combined. Measurement error in individual dietary intake variables and in breast density may have led to some underestimation of the observed R2. Some of the unexplained variation may be due to complex interactions between variables, which cannot be fully explored with the sample size available to us here and without further consideration of measurement error. In an exploratory analysis, a significant interaction was observed between changes in soluble fiber and saturated fat intake.
Ecological analysis (1) , pooled analysis of case control studies (2) , meta-analysis of cohort and case control studies (17) , and animal experimental evidence (18) all suggest a positive association between intake of fat and breast cancer incidence. However, cohort studies have shown mostly null or weakly positive associations, and a combined analysis of cohort studies showed no relationship between fat intake and breast cancer risk (3) . All observational epidemiological studies are, however, likely to be affected by the limited range of fat intake found within most populations and by error in the measurement of intake (4) . For example, an analysis of cohort studies (3) contained 4980 cases of breast cancer of whom only 84 (1.7%) reported consuming <20% of calories from fat. In the present trial, as a result of intervention with intensive dietary counseling, the range of dietary fat intake is much greater, and the mean intake of the intervention group is 20% of calories.
The strong association found here between change in dietary cholesterol and density change is in keeping with evidence in the literature of a relationship between dietary cholesterol and breast cancer risk. A review of the evidence relating cholesterol and cancer concluded that there was evidence for a small or moderate increase in risk of breast cancer associated with dietary cholesterol (19) . Dietary cholesterol intake was significantly related to increased risk of breast cancer in two combined case-control studies carried out in France and Italy (20) , in premenopausal women in an Australian case-control study (21) , marginally in a Finnish cohort study (22) , and in the Nurses Health Study cohort (1984 data), although in premenopausal women only (23) . In the recent pooled analysis of dietary fat and cholesterol data from cohort studies, only cholesterol achieved marginal significance (3) . Dietary cholesterol has also been considered as a marker for proportion of monounsaturated fat derived from olive oil versus animal sources (24) . A possible role of dietary cholesterol in the development of breast cancer needs further investigation.
It has been suggested that adolescence, when the breasts are undergoing rapid development, may be an important period for exposures to factors that may subsequently influence breast cancer risk (25 , 26) . Menopause also seems to play a key role in influencing breast cancer risk. The age-specific incidence of breast cancer increases rapidly until about age 50 after which the rate of increase slows (27) . Further, the difference in age-specific incidence seen between countries occurs after about age 50 (28) . It may be that at menopause, another period in a womans life when the breasts undergo rapid change, breast tissue is also more vulnerable to external risk factors with respect to subsequent risk. That is, if this is a time when the breasts are in the process of shifting to a lower risk state, exposure to risk factors at this time of change may affect the degree of shift. Preliminary evidence presented here from a dietary intervention trial supports this hypothesis in the sense that dietary change at menopause affected the magnitude of decrease in breast density, which has been shown to be associated with the risk of breast cancer. Further research will be necessary to determine whether diet at menopause, specifically cholesterol, total fat, and saturated fat intake, alter breast cancer risk, although disentangling the relative roles of these dietary components may be difficult.
| Footnotes |
|---|
1 Supported by grants from the Canadian Breast Cancer Research Initiative and the Ontario Ministry of Health, and by a Terry Fox Programme Project Grant from the National Cancer Institute of Canada. ![]()
2 To whom requests for reprints should be addressed, at Division of Preventive Oncology, Cancer Care Ontario, 620 University Avenue, Toronto M5G 2L7, Canada. ![]()
3 The abbreviations used is: HRT, hormone replacement therapy. ![]()
Received 6/26/98; revised 11/16/98; accepted 12/ 4/98.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. M. Blackmore, J. A. Knight, and L. Lilge Association between Transillumination Breast Spectroscopy and Quantitative Mammographic Features of the Breast Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1043 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Knight, C. M. Vachon, R. A. Vierkant, R. Vieth, J. R. Cerhan, and T. A. Sellers No association between 25-hydroxyvitamin d and mammographic density. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1988 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Boudreau, C. M. Rutter, and D. S.M. Buist The influence of statin use on breast density. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1026 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nagata, T. Matsubara, H. Fujita, Y. Nagao, C. Shibuya, Y. Kashiki, and H. Shimizu Associations of Mammographic Density with Dietary Factors in Japanese Women Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2877 - 2880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Neuhouser Soy and Mammographic Breast Density: Plausible Hypothesis but Limited Evidence in Humans J. Nutr., November 1, 2004; 134(11): 2911 - 2912. [Full Text] [PDF] |
||||
![]() |
J. A. Harvey and V. E. Bovbjerg Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk Radiology, January 1, 2004; 230(1): 29 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Greendale, B. A. Reboussin, S. Slone, C. Wasilauskas, M. C. Pike, and G. Ursin Postmenopausal Hormone Therapy and Change in Mammographic Density J Natl Cancer Inst, January 1, 2003; 95(1): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Chlebowski, E. Aiello, and A. McTiernan Weight Loss in Breast Cancer Patient Management J. Clin. Oncol., February 15, 2002; 20(4): 1128 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Singletary and S. M. Gapstur Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms JAMA, November 7, 2001; 286(17): 2143 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Clemons and P. Goss Estrogen and the Risk of Breast Cancer N. Engl. J. Med., January 25, 2001; 344(4): 276 - 285. [Full Text] [PDF] |
||||
![]() |
C. M. Vachon, L. H. Kushi, J. R. Cerhan, C. C. Kuni, and T. A. Sellers Association of Diet and Mammographic Breast Density in the Minnesota Breast Cancer Family Cohort Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 151 - 160. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |